Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy

Hijazi, Ziad, Oldgren, Jonas, Andersson, Ulrika, Connolly, Stuart J., Ezekowitz, Michael D., Hohnloser, Stefan H., Reilly, Paul A., Vinereanu, Dragos, Siegbahn, Agneta, Yusuf, Salim, Wallentin, Lars·2012·Circulation
DOI 10.1161/circulationaha.111.038729

Cited by (400)

Items 101–200 of 400

  1. Universal MI Definition Update for Cardiovascular Disease
    Harvey Douglas White, Kristian A. Thygesen, Joseph S. Alpert, Allan S. Jaffe · 2014 · Current Cardiology Reports
  2. Impact of Atrial Fibrillation During ST-Segment–Elevation Myocardial Infarction on Infarct Characteristics and Prognosis
    Sebastian J. Reinstadler, Thomas Stiermaier, Charlotte Eitel, Georg Friedrich Fuernau, Mohammed F. Saad, Janine Pöss, Suzanne de Waha, Meinhard Mende, Steffen Desch, Bernhard Metzler et al. · 2018 · Circulation Cardiovascular Imaging
  3. Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study
    Lucas Yixi Xing, Søren Zöga Diederichsen, Søren Højberg, Derk Wolfgang Krieger, Claus Graff, Ruth Frikke‐Schmidt, MORTEN SALLING OLESEN, Axel Brandes, Lars Køber, Ketil Haugan et al. · 2023 · Circulation
  4. Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation
    Wengen Zhu, Linghua Fu, Ying Ding, Lin Huang, Zhenyan Xu, Jinzhu Hu, Kui Hong · 2016 · International Journal of Cardiology
  5. The Significance Of Troponin Elevation In Atrial Fibrillation
    Juan Pablo Costabel, Lucrecia María Burgos, Marcelo Trivi · 2017 · Journal of Atrial Fibrillation
  6. Identification of Markers Associated With Development of Stroke in “Clinically Low‐Risk” Atrial Fibrillation Patients
    Seung Yong Shin, Sang Jin Han, Jin Seok Kim, Sung Il Im, Jaemin Shim, Jinhee Ahn, Eun Mi Lee, Yae Min Park, Jun Hyung Kim, Gregory Y.H. Lip et al. · 2019 · Journal of the American Heart Association
  7. Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events
    Bibek Gyanwali, Mitchell K.P. Lai, Benedict Lui, Oi Wah Liew, Narayanaswamy Venketasubramanian, Mark Richards, Christopher Chen, Saima Hilal · 2021 · Stroke
  8. Update on atrial fibrillation
    Amanulla Khaji, Peter Russell Kowey · 2016 · Trends in Cardiovascular Medicine
  9. Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
    Wern Yew Ding, Stephanie Lucy Harrison, Dhiraj Gupta, Gregory Y.H. Lip, Deirdre A. Lane · 2020 · Frontiers in Medicine
  10. Heart and Brain Interactions--the Akershus Cardiac Examination (ACE) 1950 Study Design.
    Trygve Berge, Thea Vigen, Mohammad Osman Pervez, Håkon Ihle‐Hansen, Magnus Nakrem Lyngbakken, Torbjørn Omland, Pål Smith, Kjetil Steine, Helge Rørvik Røsjø, Arnljot Tveit · 2015 · PubMed
  11. Causes of Troponin Elevation and Associated Mortality in Young Patients
    Candace Wu, Avinainder Singh, Bradley Collins, Amber Fatima, Arman Qamar, Ankur Gupta, Jon Mark Hainer, Josh Klein, Petr Jarolı́m, Marcelo F. Di Carli et al. · 2018 · The American Journal of Medicine
  12. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non–ST-Elevation Acute Coronary Syndrome
    Daniel P. Lindholm, Stefan Karl James, Maria Bertilsson, Richard Clinton Becker, Christopher Paul Cannon, Evangelos Giannitsis, Robert A. Harrington, Anders Himmelmänn, Frederic P Kontny, Agneta Siegbahn et al. · 2016 · Clinical Chemistry
  13. N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation
    Emma Svennberg, Peter Henriksson, Johan Engdahl, Ziad Hijazi, Faris Al‐Khalili, Leif Friberg, Viveka Frykman · 2017 · Heart
  14. Biomarkers of Atrial Fibrillation in Hypertension
    Costas P. Tsioufis, D. Konstantinidis, Ilias Nikolakopoulos, Evi Vemmou, Theodoros Kalos, Georgios A. Georgiopoulos, Nikolaos Vogiatzakis, Aris Ifantis, Konstantinou Konstantinou, Vasiliki Gennimata et al. · 2017 · Current Medicinal Chemistry
  15. The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke
    Juqian Zhang, Radosław Lenarczyk, Francisco R. Marín, Katarzyna Małaczyńska-Rajpold, Jędrzej Kosiuk, Wolfram Doehner, Isabelle C. Van Gelder, Geraldine Lee, Jeroen Hendriks, Gregory Y.H. Lip et al. · 2020 · EP Europace
  16. Cardiac troponin and adverse outcomes in atrial fibrillation: A meta-analysis
    Yichuan Fan, Xingzhi Zhao, Xiaodong Li, Nan Li, Xinhua Hu · 2017 · Clinica Chimica Acta
  17. Circulating cardiac biomarkers, structural brain changes, and dementia: Emerging insights and perspectives
    Märit Jensen, Tanja Zeller, Raphael Twerenbold, Götz Thomalla · 2023 · Alzheimer s & Dementia
  18. Causes of Death Among Persons Who Survive an Acute Ischemic Stroke
    Shuai Zhang, Wenbin He, Nai‐Hong Chen · 2014 · Current Neurology and Neuroscience Reports
  19. Early rule-out of acute coronary syndrome using undetectable levels of high sensitivity troponin T
    Johan Thelin, Olle Melander, Bertil Öhlin · 2014 · European Heart Journal Acute Cardiovascular Care
  20. The changing circumstance of atrial fibrillation ‐ progress towards precision medicine
    A. John Camm, Irina Savelieva, Tatjana Potpara, Gerhardt Hindriks, Laurent Pison, Carina Blomström‐Lundqvist · 2016 · Journal of Internal Medicine
  21. The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation
    Paul L. Hess, Jeff S. Healey, Christopher Bull Granger, Stuart J. Connolly, Paul Ziegler, John Hunter Alexander, Peter Russell Kowey, Christian Thomas Ruff, Greg Flaker, Jonathan L. Halperin et al. · 2017 · JAMA Cardiology
  22. Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time
    Ziad Hijazi, Bertil Lindahl, Jonas Oldgren, Ulrika Andersson, Johan Lindbäck, Christopher Bull Granger, John Hunter Alexander, Bernard John Gersh, Michael Hanna, Veli‐Pekka Harjola et al. · 2017 · Journal of the American Heart Association
  23. Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
    Brian Kerr, Lisa Brandon · 2022 · IJC Heart & Vasculature
  24. Cardioembolic Stroke Diagnosis Using Blood Biomarkers
    Víctor Llombart, Teresa García‐Berrocoso, Alejandro Bustamante, Israel Fernández‐Cadenas, Joan Montaner · 2014 · Current Cardiology Reviews
  25. Mean platelet volume is associated with the presence of left atrial stasis in patients with non-valvular atrial fibrillation
    Rui Andre Providencia, Ana Faustino, Luís Paiva, Andréia Silva Fernandes, Sérgio Barra, Joana M. Pimenta, Joana Trigo, Ana Botelho, António Leitão‐Marques · 2013 · BMC Cardiovascular Disorders
  26. Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary
    Gregory Y.H. Lip · 2013 · Journal of Thrombosis and Haemostasis
  27. Multiple Blood Biomarkers and Stroke Risk in Atrial Fibrillation: The REGARDS Study
    Matthew J. Singleton, Ya Yuan, Farah Z. Dawood, George Howard, Suzanne E. Judd, Neil A. Zakai, Virginia J. Howard, David M. Herrington, Elsayed Z. Soliman, Mary Cushman · 2021 · Journal of the American Heart Association
  28. Lone atrial fibrillation - an overview
    Tatjana Potpara, Gregory Y.H. Lip · 2013 · International Journal of Clinical Practice
  29. Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure
    Yasuhiro Hamatani, Moritake Iguchi, Kentaro Ueno, Yuya Aono, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe et al. · 2020 · Heart
  30. Sprint Fidelis Lead Fractures in Patients With Cardiac Resynchronization Therapy Devices
    Ratika Parkash, Bernard Thibault, Larry D. Sterns, John L. Sapp, Andrew David Krahn, Mario R. Talajic, Marilynn Luce, Elizabeth Yetisir, Patricia Theoret-Patrick, George A. Wells et al. · 2012 · Circulation
  31. New perspectives on atrial fibrillation and stroke
    NAZEM W. AKOUM · 2016 · Heart
  32. Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA2DS2-VASc and HAS-BLED scores using multiple biomarkers
    Vanessa Roldán, José Miguel Rivera‐Caravaca, Alena Shantsila, Amaya García-Fernández, María Asunción Esteve‐Pastor, Juan Antonio Vilchez, Marta Romera, Mariano Valdés, Vicente Vicente, Francisco R. Marín et al. · 2017 · Annals of Medicine
  33. Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future Directions
    Pankaj Mathur, Hakan Paydak, Sharmilan Thanendrarajan, Frits van Rhee · 2015 · Clinical Lymphoma Myeloma & Leukemia
  34. Predictors of significant coronary artery disease in atrial fibrillation: Are cardiac troponins a useful measure
    Alaa Alghamry, John Hanna, Anita Maria Pelecanos, Stephen J. Kyranis, Vinod Khelgi, Peter K O'Rourke, Oran Carroll, Cassie Oxenford, Swetha Rangaswamaiah, Christopher Tan · 2016 · International Journal of Cardiology
  35. The Multiple Causes of Stroke in Atrial Fibrillation: Thinking Broadly
    Atlantic D’Souza, Kenneth Butcher, Brian H Buck · 2018 · Canadian Journal of Cardiology
  36. North American Thrombosis Forum, AF Action Initiative Consensus Document
    Christian Thomas Ruff, Jack Ansell, Richard Clinton Becker, Emelia J. Benjamin, David J. Deicicchi, N.A. Mark Estes, Michael D. Ezekowitz, John R. Fanikos, Jawed Fareed, David A. Garcia et al. · 2016 · The American Journal of Medicine
  37. NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack
    Emilio Rodríguez Castro, Pablo Hervella, Iria López‐Dequidt, Susana Arias-Rivas, María Santamaría-Cadavid, Ignacio López-Loureiro, Andrés da Silva‐Candal, María Pérez‐Mato, Tomás Sobrino, Francisco Campos et al. · 2019 · International Journal of Cardiology
  38. Improved Rate Control Reduces Cardiac Troponin T Levels in Permanent Atrial Fibrillation
    Sara Reinvik Ulimoen, Steve Enger, Jon Norseth, Are Hugo Pripp, Michael Abdelnoor, Harald Arnesen, Knut Gjesdal, Arnljot Tveit · 2014 · Clinical Cardiology
  39. Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis
    Ichiro Sakuma, Shinichiro Uchiyama, Hirotsugu Atarashi, Hiroshi Inoue, Takanari Kitazono, Takeshi Yamashita, Wataru Shimizu, Takanori Ikeda, Masahiro Kamouchi, Koichi Kaikita et al. · 2019 · Heart and Vessels
  40. Optimal rate control in dogs with atrial fibrillation—ORCA study—Multicenter prospective observational study: Prognostic impact and predictors of rate control
    Brigite Pedro, Antonia Mavropoulou, Mark A. Oyama, Chris Linney, J. Neves, Joanna Dukes‐McEwan, Ana Patrícia Fontes-Sousa, Anna R. Gelzer · 2023 · Journal of Veterinary Internal Medicine
  41. C-Reactive Protein and B-Type Natriuretic Peptide Yield Either a Non-Significant or a Modest Incremental Value to Traditional Risk Factors in Predicting Long-Term Overall Mortality in Older Adults
    Alline Maria R. Beleigoli, Eric H. Boersma, Maria de Fátima Haueisen Sander Diniz, Pedro Guatimosim Vidigal, Maria Fernanda Lima‐Costa, Antônio Luiz Pinho Ribeiro · 2013 · PLoS ONE
  42. Perspectives on the Value of Biomarkers in Acute Cardiac Care and Implications for Strategic Management
    Antoine Kossaify, Annie Garcia, Sami Succar, Antoine Ibrahim, Nicolas Moussallem, Mikhael Kossaify, Gilles Grollier · 2013 · Biomarker Insights
  43. Abnormal troponin level as short-term predictor of poor outcome in acute atrial fibrillation
    Alberto Conti, Yuri Mariannini, Gabriele Viviani, Claudio Poggioni, Gabriele Cerini, Margherita Luzzi, Maurizio Zanobetti, Francesca Innocenti, Luigi Padeletti, Gian Franco Gensini · 2013 · The American Journal of Emergency Medicine
  44. Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation
    Jan Daniel Niederdöckl, Alexander Simon, Sebastian Schnaubelt, Nikola Schuetz, Roberta Laggner, Patrick Sulzgruber, Alexander Oskar Spiel, Harald Herkner, Anton Norbert Laggner, Hans Domanovits · 2018 · Heart
  45. Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
    Christian Mahnkopf, Younghoon Kwon, NAZEM W. AKOUM · 2021 · Arrhythmia & Electrophysiology Review
  46. Untreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment options
    Sérgio Barra, Simon P. Fynn · 2014 · Journal of the Saudi Heart Association
  47. Prognostic significance of troponin level in 3121 patients presenting with atrial fibrillation (The NIHR Health Informatics Collaborative TROP‐AF study)
    Amit Kaura, Ahran D. Arnold, Vasileios F. Panoulas, Benjamin Glampson, Jim Davies, Abdulrahim Mulla, Kerrie Woods, Joe Omigie, Anoop D Shah, Keith M. Channon et al. · 2020 · Journal of the American Heart Association
  48. The Association of CHA2DS2-VASc Score and Blood Biomarkers with Ischemic Stroke Outcomes: The Belgrade Stroke Study
    Tatjana Potpara, Marija M. Polovina, Dijana Djikic, Jelena Marinković, Nikola I. Kocev, Gregory Y.H. Lip · 2014 · PLoS ONE
  49. CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation
    Paulina Wakula, Benjamin Neumann, Jens Kienemund, Eva Thon-Gutschi, Tatjana Stojaković, Martin Manninger, Daniel Scherr, Hubert Scharnagl, Martin Kapl, Burkert Mathias Pieske et al. · 2016 · EP Europace
  50. Inflammation as a risk factor for stroke in atrial fibrillation: data from a microarray data analysis
    Yingyuan Li, Wulin Tan, Fang Ye, Shihong Wen, Rong Hua Hu, Xiaoying Cai, Kebing Wang, Zhongxing Wang · 2020 · Journal of International Medical Research
  51. Cardioversion safety in patients with nonvalvular atrial fibrillation
    Rui Andre Providencia, Ana Faustino, Luís Paiva, Joana Trigo, Ana Botelho, José Hamilton Matheus Nascimento, António Leitão‐Marques · 2012 · Blood Coagulation & Fibrinolysis
  52. Prognostic value of elevated high-sensitivity cardiac troponin T in patients admitted to an emergency department with atrial fibrillation
    Kiril M. Stoyanov, Evangelos Giannitsis, Moritz Biener, Matthias Mueller‐Hennessen, Katharina Arens, Hugo Albert Katus, Mehrshad Vafaie · 2017 · EP Europace
  53. Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation
    Julia Aulin, Karl Sjölin, Johan Lindbäck, Alexander Philipp Benz, John W. Eikelboom, Ziad Hijazi, Kim Kultima, Jonas Oldgren, Lars C. Wallentin, Joachim Burman et al. · 2024 · Circulation
  54. Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation
    Roberto Cangemi, Pasquale Pignatelli, Roberto Carnevale, Gino Roberto Corazza, Daniele Pastori, Alessio Farcomeni, Stefania Basili, Giovanni Davı̀, Domenico Ferro, William Robert Hiatt et al. · 2013 · International Journal of Cardiology
  55. Dynamic high-sensitivity troponin elevations in atrial fibrillation patients might not be associated with significant coronary artery disease
    Johan Thelin, Olle Melander · 2017 · BMC Cardiovascular Disorders
  56. Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
    Roopinder Kaur Sandhu, Justin Adrian Ezekowitz, Ziad Hijazi, Johan Westerbergh, Julia Aulin, John Hunter Alexander, Christopher Bull Granger, Sigrun Halvorsen, Michael S. Hanna, Renato D. Lópes et al. · 2018 · Open Heart
  57. N‐terminal pro–brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk
    Liselotte W. Wijsman, Behnam Sabayan, Peter van Vliet, Stella Trompet, Wouter de Ruijter, Rosalinde K. E. Poortvliet, Petra G. van Peet, Jacobijn Gussekloo, J. Wouter Jukema, David J. Stott et al. · 2014 · Annals of Neurology
  58. Short- and long-term individual variation in NT-proBNP levels in patients with stable coronary artery disease
    Anna M. Nordenskjöld, Håkan K. Ahlström, Kai M. Eggers, Ole Fröbert, Per Venge, Bertil Lindahl · 2013 · Clinica Chimica Acta
  59. Atrial fibrillation, elevated troponin, ischemic stroke and adverse outcomes: understanding the connection
    Rui Andre Providencia, Sérgio Barra, Luís Paiva · 2013 · Clinical Research in Cardiology
  60. NT‐proBNP is associated with mortality and adverse cardiac events in patients with atrial fibrillation presenting to the emergency department
    Marijn J. Holl, Ewout J. van den Bos, Ron T. van Domburg, Michael A. Fouraux, Marcel J.M. Kofflard · 2018 · Clinical Cardiology
  61. Relationship of troponin to incident atrial fibrillation occurrence, recurrence after radiofrequency ablation and prognosis: a systematic review, meta-analysis and meta-regression
    Ying Bai, Shi-Dong Guo, Yue Liu, Changsheng Ma, Gregory Y.H. Lip · 2018 · Biomarkers
  62. A novel prognostic tool to predict mortality in patients with atrial fibrillation: The BASIC-AF risk score
    Athanasios Samaras, Αναστάσιος Κάρτας, Evangelos Akrivos, George Fotos, George Dividis, Dimitra Vasdeki, Eleni Vrana, Georgios P. Rampidis, Haralambos I. Karvounis, George A. Giannakoulas et al. · 2021 · Hellenic Journal of Cardiology
  63. Diagnosing Paroxysmal Atrial Fibrillation: Are Biomarkers the Solution to This Elusive Arrhythmia?
    Philippa J. Howlett, Fiona Hatch, Vadim Alexeenko, Rita I. Jabr, E. W. Leatham, Christopher Henry Fry · 2015 · BioMed Research International
  64. Stroke Prevention in Atrial Fibrillation
    Christos Voukalis, Eduard Shantsila, Gregory Y.H. Lip · 2017 · The Journal of the Royal College of Physicians of Edinburgh
  65. Prognostic Usefulness of Left Ventricular Hypertrophy by Electrocardiography in Patients With Atrial Fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study)
    Paolo Verdecchia, Gianpaolo Reboldi, Giuseppe Di Pasquale, Giovanni Mazzotta, Giuseppe Ambrosio, Sean Yang, Janice M. Pogue, Lars C. Wallentin, Michael D. Ezekowitz, Stuart J. Connolly et al. · 2013 · The American Journal of Cardiology
  66. Phenolics Extracted from Jasminum sambac Mitigates Diabetic Cardiomyopathy by Modulating Oxidative Stress, Apoptotic Mediators and the Nfr-2/HO-1 Pathway in Alloxan-Induced Diabetic Rats
    Urooj Umar, Sibtain Ahmed, Asra Iftikhar, Maryam Iftikhar, Wafa Majeed, Atika Liaqat, Sana Shahzad, Mateen Abbas, Tahir Mehmood, Farooq Anwar · 2023 · Molecules
  67. Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure
    Claire Mac Sweeney, Fiona Ryan, Mark T. Ledwidge, Cristín A. Ryan, Kenneth McDonald, Chris J Watson, Rebabonye B. Pharithi, Joe Gallagher · 2019 · Cochrane Database of Systematic Reviews
  68. Atrial fibrillation in athletes: From epidemiology to treatment in the novel oral anticoagulants era
    Giuseppe Damiano Sanna, Eleonora Gabrielli, Elena De Vito, Giuseppe Nusdeo, Domenico Prisco, Guido Parodi · 2018 · Journal of Cardiology
  69. Mean corpuscular volume and red cell distribution width as predictors of left atrial stasis in patients with non-valvular atrial fibrillation.
    Rui Andre Providencia, Maria João Ferreira, Lino Manuel Martins Gonçalves, Ana Faustino, Luís Paiva, Andréia Silva Fernandes, Sérgio Barra, Joana M. Pimenta, António Leitão‐Marques · 2013 · Europe PMC (PubMed Central)
  70. Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project
    José Miguel Rivera‐Caravaca, Vanessa Roldán, Marta Romera, María Asunción Esteve‐Pastor, Mariano Valdés, Gregory Y.H. Lip, Vicente Vicente, Francisco R. Marín · 2018 · Journal of General Internal Medicine
  71. Atrial Fibrillation Detection and Load: Knowledge Gaps Related to Stroke Prevention
    Eric Edward Smith, Shadi R. Yaghi, Luciano Alberto Sposato, Marc Fisher, Joseph P. Broderick, Alvin S. Das, Mitchell S.V. Elkind, Larry B. Goldstein, M. Edip Gurol, Hooman Kamel et al. · 2023 · Stroke
  72. Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
    Konstantinos I. Gkarmiris, Johan Lindbäck, John Hunter Alexander, Christopher Bull Granger, Peter Kastner, Renato D. Lópes, André Ziegler, Jonas Oldgren, Agneta G Siegbahn, Lars C. Wallentin et al. · 2024 · Journal of the American Heart Association
  73. Plasma B-type Natriuretic Peptide as a Predictor of Cardiovascular Events in Subjects with Atrial Fibrillation: A Community-Based Study
    Motoyuki Nakamura, Yorihiko Koeda, Fumitaka Tanaka, Toshiyuki Onoda, Kazuyoshi Itai, Masaki Ohsawa, Kozo Tanno, Kiyomi Sakata, Shinichi Omama, Yasuhiro Ishibashi et al. · 2013 · PLoS ONE
  74. Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry
    Jelena Kornej, Jędrzej Kosiuk, Gerhard Hindricks, Arash Arya, Philipp Sommer, Sascha Rolf, Daniela Husser, Gregory Y.H. Lip, Andreas Bollmann · 2015 · Clinical Research in Cardiology
  75. Emerging Tools for Stroke Prevention in Atrial Fibrillation
    Christos Voukalis, Gregory Y.H. Lip, Eduard Shantsila · 2016 · EBioMedicine
  76. Biomarkers Associated with Stroke Risk in Atrial Fibrillation
    Adam Ioannou, Νικόλαος Παπαγεωργίου, Debbie Falconer, Onkar Rehal, Emma Sewart, Effimia Maria Zacharia, Konstantinos P. Toutouzas, Charalambos V. Vlachopoulos, Gerasimos Siasos, Costas P. Tsioufis et al. · 2017 · Current Medicinal Chemistry
  77. Biomarkers of Atrial Fibrillation in Metabolic Syndrome
    Christos Georgakopoulos, Charalambos V. Vlachopoulos, Georgios Lazaros, Dimitrios M. Tousoulis · 2017 · Current Medicinal Chemistry
  78. Elevated troponin levels are associated with early neurological worsening in ischemic stroke with atrial fibrillation
    Ki‐Woong Nam, Chi Kyung Kim, Sungwook Yu, Jong‐Won Chung, Oh Young Bang, Gyeong‐Moon Kim, Jin‐Man Jung, Tae‐Jin Song, Yong‐Jae Kim, Bum Joon Kim et al. · 2020 · Scientific Reports
  79. Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.
    Ioanna C. Koniari, Eleni Artopoulou, Dimitrios Velissaris, Mark Ainslie, Virginia Mplani, Georgia Karavasili, Nicholas George Kounis, Grigorios Tsigkas · 2021 · PubMed Central
  80. High-sensitivity cardiac troponin T as an independent predictor of stroke in patients admitted to an emergency department with atrial fibrillation
    Mehrshad Vafaie, Evangelos Giannitsis, Matthias Mueller‐Hennessen, Moritz Biener, Elena Makarenko, Buelent Yueksel, Hugo Albert Katus, Kiril M. Stoyanov · 2019 · PLoS ONE
  81. High Sensitivity Cardiac Troponin T and Cognitive Function in the Oldest Old: The Leiden 85-Plus Study
    Bertens, Anne Suzanne, Sabayan, Behnam, de Craen, Anton J.M., Van der Mast, Roos C., Gussekloo, Jacobijn · 2017 · Journal of Alzheimer's Disease
  82. A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
    Luxiang Shang, Ling Zhang, Yankai Guo, Huaxin Sun, Xiaoxue Zhang, Yakun Bo, Xianhui Zhou, Baopeng Tang · 2021 · Frontiers in Cardiovascular Medicine
  83. Association between left atrial low-voltage area, serum apoptosis, and fibrosis biomarkers and incidence of silent cerebral events after catheter ablation of atrial fibrillation
    Patrick Müller, Johannes Maier, Johannes W. Dietrich, Sebastian Barth, Daniel P. Griese, Fabian Schiedat, Attila Szöllösi, Philipp Halbfaß, Karin Nentwich, Markus Roos et al. · 2015 · Journal of Interventional Cardiac Electrophysiology
  84. Explanatory Power and Prognostic Implications of Factors Associated with Troponin Elevation in Acute Ischemic Stroke
    Sung‐Ho Ahn, Ji Sung Lee, Mi-Sook Yun, Junghee Han, Soo‐Young Kim, Young‐Hak Kim, Sang-Hyun Lee, Min‐Gyu Park, Kyung‐Pil Park, Dong‐Wha Kang et al. · 2023 · Journal of Stroke
  85. The role of interleukins in pathogenesis and prognosis of atrial fibrillation
    Mohammad Erfan Lotfi, Parmida Sadat Pezeshki, Nima Rezaei · 2023 · Expert Review of Clinical Immunology
  86. Stroke in Atrial Fibrillation and Other Atrial Dysrhythmias
    Hizir Ozdemir, Dimitrios Sagris, Gregory Y.H. Lip, Azmil H. Abdul‐Rahim · 2023 · Current Cardiology Reports
  87. Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA 2 DS 2 -VASc Score 1 in Men, 2 in Women) Be Anticoagulated?
    John A. Savino, Jonathan L. Halperin · 2016 · Circulation
  88. Biomarkers of Atrial Fibrillation: Which One Is a True Marker?
    Pipin Ardhianto, Yoga Yuniadi · 2019 · Cardiology Research and Practice
  89. Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review
    Irum Kotadia, Iain Sim, Rahul K Mukherjee, Daniel O’Hare, Amedeo Chiribiri, Jonathan Birns, Ajay Bhalla, Mark D O'Neill, Steven Edwin Williams · 2021 · Journal of the American Heart Association
  90. Atrial fibrillation and stroke: importance of left atrium as assessed by echocardiography
    Yoshinobu Suwa, Yoko Miyasaka, Naoki Taniguchi, Shoko Harada, Eri Nakai, Ichiro Shiojima · 2022 · Journal of Echocardiography
  91. β-Trace Protein and Prognosis in Patients With Atrial Fibrillation Receiving Anticoagulation Treatment
    Juan Antonio Vilchez, Vanessa Roldán, Sergio Manzano‐Fernández, Hermógenes Fernández, Francisco V. Avilés-Plaza, Pedro Martínez-Hernández, Vicente Vicente, Mariano Valdés, Francisco R. Marín, Gregory Y.H. Lip · 2013 · CHEST Journal
  92. Troponin levels after ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial
    Máté Vámos, Jeff S. Healey, Jia Wang, Gábor Zoltán Duray, Stuart J. Connolly, Lieselot van Erven, Xavier Viñolas, Jörg Neuzner, Michael Glikson, Stefan Hans Hohnloser · 2015 · Heart Rhythm
  93. Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation
    Lars C. Wallentin, Johan Lindbäck, Ziad Hijazi, Jonas Oldgren, Anthony Carnicelli, John Hunter Alexander, David D. Berg, John W. Eikelboom, Shinya Goto, Renato D. Lópes et al. · 2025 · Journal of the American College of Cardiology
  94. Association of Heart Rate With Troponin Levels Among Patients With Symptomatic Atrial Fibrillation
    Jussi-Pekka Pouru, Samuli Jaakkola, Fausto Biancari, Tuomas Kiviniemi, Ilpo O. Nuotio, Juhani K.E. Airaksinen · 2020 · JAMA Network Open
  95. Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response
    Anna Rago, Ciro Pirozzi, Antonello D’Andrea, Pierpaolo Di Micco, Andrea Antonio Papa, Antonio D’Onofrio, Paolo Golino, Gerardo Nigro, Vincenzo Russo · 2023 · Medicina
  96. Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation
    Gian Marco De Marchis, Philipp Krisai, Laura Werlen, Tim Sinnecker, Stefanie Aeschbacher, Tolga Daniel Dittrich, Alexandros A. Polymeris, Michael Coslovsky, Manuel R. Blum, Nicolas Rodondi et al. · 2023 · Stroke
  97. The Evolving Role of Stroke Prediction Schemes for Patients With Atrial Fibrillation
    Andrew C.T. Ha, Jeff S. Healey · 2013 · Canadian Journal of Cardiology
  98. Usefulness of High-Sensitivity Troponin I to Predict Outcome in Patients With Newly Detected Atrial Fibrillation
    Bum Sung Kim, Chang Hee Kwon, Haseong Chang, Sung Hea Kim, Hyun Joong Kim, Hweung Kon Hwang, Sang-Man Chung · 2019 · The American Journal of Cardiology
  99. Prognostic value of chemokines in patients with newly diagnosed atrial fibrillation
    Jiaqi Huang, Na Wu, Ying Xiang, Long Wu, Chengying Li, Zhiquan Yuan, Xiaoyue Jia, Zhihui Zhang, Li Zhong, Yafei Li · 2020 · International Journal of Cardiology
  100. Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC‐AF risk scores
    Ziad Hijazi, Johan Lindbäck, Jonas Oldgren, Alexander Philipp Benz, John Hunter Alexander, Stuart J. Connolly, John W. Eikelboom, Christopher Bull Granger, Renato D. Lópes, Agneta G Siegbahn et al. · 2023 · American Heart Journal